Literature DB >> 24072810

Going from social neuroscience to schizophrenia clinical trials.

Michael F Green1, David L Penn.   

Abstract

The goals of the project Social Cognition and Functioning in Schizophrenia (SCAF) were to (1) identify the domains to target from social neuroscience for translation to clinical schizophrenia research, (2) identify the paradigms that represent these domains for which the neural substrates are well documented, (3) adapt these paradigms for use in schizophrenia clinical trials, (4) assess the psychometric properties of these measures, and (5) assess the external validity of these measures. The articles in this theme section present the initial findings from the SCAF project. As more training and psychopharmacological studies evaluate interventions for social cognition, the articles in this theme section are intended to serve as a guide for informed design decisions about possible endpoints in clinical trials.

Entities:  

Keywords:  clinical trials; schizophrenia; social cognition; social neuroscience

Mesh:

Year:  2013        PMID: 24072810      PMCID: PMC3796090          DOI: 10.1093/schbul/sbt128

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  10 in total

1.  Improving social perception in schizophrenia: the role of oxytocin.

Authors:  M Fischer-Shofty; M Brüne; A Ebert; D Shefet; Y Levkovitz; S G Shamay-Tsoory
Journal:  Schizophr Res       Date:  2013-02-19       Impact factor: 4.939

2.  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Authors:  Michael F Green; Gerhard Hellemann; William P Horan; Junghee Lee; Jonathan K Wynn
Journal:  Arch Gen Psychiatry       Date:  2012-12

3.  Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium.

Authors:  James M Gold; Deanna M Barch; Cameron S Carter; Steven Dakin; Steven J Luck; Angus W MacDonald; J Daniel Ragland; Charan Ranganath; Ilona Kovacs; Steven M Silverstein; Milton Strauss
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

4.  Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders.

Authors:  William P Horan; Robert S Kern; Cory Tripp; Gerhard Hellemann; Jonathan K Wynn; Morris Bell; Stephen R Marder; Michael F Green
Journal:  J Psychiatr Res       Date:  2011-03-04       Impact factor: 4.791

5.  Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.

Authors:  Cort A Pedersen; Clare M Gibson; Shane W Rau; Kayvon Salimi; Kelly L Smedley; Robin L Casey; Jane Leserman; L Fredrik Jarskog; David L Penn
Journal:  Schizophr Res       Date:  2011-08-15       Impact factor: 4.939

6.  Remediation of impairments in facial affect recognition in schizophrenia: efficacy and specificity of a new training program.

Authors:  Wolfgang Wölwer; Nicole Frommann; Sabine Halfmann; Anja Piaszek; Marcus Streit; Wolfgang Gaebel
Journal:  Schizophr Res       Date:  2005-08-24       Impact factor: 4.939

7.  Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study.

Authors:  David L Roberts; David L Penn
Journal:  Psychiatry Res       Date:  2009-03-09       Impact factor: 3.222

8.  Effects of single dose intranasal oxytocin on social cognition in schizophrenia.

Authors:  Michael C Davis; Junghee Lee; William P Horan; Angelika D Clarke; Mark R McGee; Michael F Green; Stephen R Marder
Journal:  Schizophr Res       Date:  2013-05-12       Impact factor: 4.939

9.  The social-emotional processing stream: five core constructs and their translational potential for schizophrenia and beyond.

Authors:  Kevin N Ochsner
Journal:  Biol Psychiatry       Date:  2008-07-01       Impact factor: 13.382

Review 10.  Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.

Authors:  Cameron S Carter; Deanna M Barch
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

  10 in total
  4 in total

1.  Social Cognition Psychometric Evaluation: Results of the Initial Psychometric Study.

Authors:  Amy E Pinkham; David L Penn; Michael F Green; Philip D Harvey
Journal:  Schizophr Bull       Date:  2015-05-04       Impact factor: 9.306

Review 2.  Social cognition as an RDoC domain.

Authors:  Ruben C Gur; Raquel E Gur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-11-26       Impact factor: 3.568

3.  Social Cognition Psychometric Evaluation: Results of the Final Validation Study.

Authors:  Amy E Pinkham; Philip D Harvey; David L Penn
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

4.  Social Cognition and Schizophrenia: Unresolved Issues and New Challenges in a Maturing Field of Research.

Authors:  Anja Vaskinn; William P Horan
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.